Vanguard Group
CRDF icon

Vanguard Group’s Cardiff Oncology CRDF Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.7M Buy
3,728,334
+612,965
+20% +$1.93M ﹤0.01% 2812
2025
Q1
$9.78M Buy
3,115,369
+830,452
+36% +$2.61M ﹤0.01% 2855
2024
Q4
$9.92M Buy
2,284,917
+113,473
+5% +$492K ﹤0.01% 2966
2024
Q3
$5.8M Buy
2,171,444
+35,106
+2% +$93.7K ﹤0.01% 3214
2024
Q2
$4.74M Buy
2,136,338
+215,081
+11% +$477K ﹤0.01% 3280
2024
Q1
$10.3M Buy
1,921,257
+9,468
+0.5% +$50.6K ﹤0.01% 2952
2023
Q4
$2.83M Sell
1,911,789
-31,129
-2% -$46.1K ﹤0.01% 3475
2023
Q3
$2.7M Hold
1,942,918
﹤0.01% 3488
2023
Q2
$2.86M Hold
1,942,918
﹤0.01% 3541
2023
Q1
$3.21M Hold
1,942,918
﹤0.01% 3501
2022
Q4
$2.72M Buy
1,942,918
+870
+0% +$1.22K ﹤0.01% 3552
2022
Q3
$2.99M Buy
1,942,048
+186,392
+11% +$287K ﹤0.01% 3586
2022
Q2
$3.86M Sell
1,755,656
-157,757
-8% -$347K ﹤0.01% 3514
2022
Q1
$4.75M Sell
1,913,413
-45,522
-2% -$113K ﹤0.01% 3554
2021
Q4
$11.8M Buy
1,958,935
+145,987
+8% +$877K ﹤0.01% 3128
2021
Q3
$12.1M Buy
1,812,948
+166,904
+10% +$1.11M ﹤0.01% 3136
2021
Q2
$10.9M Buy
1,646,044
+72,134
+5% +$480K ﹤0.01% 3153
2021
Q1
$14.6M Buy
1,573,910
+27,533
+2% +$255K ﹤0.01% 2949
2020
Q4
$27.8M Buy
1,546,377
+514,975
+50% +$9.26M ﹤0.01% 2481
2020
Q3
$14.6M Buy
1,031,402
+737,026
+250% +$10.5M ﹤0.01% 2600
2020
Q2
$1.48M Buy
294,376
+23,593
+9% +$118K ﹤0.01% 3521
2020
Q1
$273K Sell
270,783
-3,136
-1% -$3.16K ﹤0.01% 3811
2019
Q4
$340K Hold
273,919
﹤0.01% 3865
2019
Q3
$414K Sell
273,919
-11,231
-4% -$17K ﹤0.01% 3856
2019
Q2
$713K Buy
285,150
+217,386
+321% +$544K ﹤0.01% 3760
2019
Q1
$254K Sell
67,764
-282,335
-81% -$1.06M ﹤0.01% 3879
2018
Q4
$184K Buy
350,099
+111,070
+46% +$58.4K ﹤0.01% 3914
2018
Q3
$195K Buy
239,029
+199,767
+509% +$163K ﹤0.01% 4007
2018
Q2
$30K Sell
39,262
-945,852
-96% -$723K ﹤0.01% 4115
2018
Q1
$344K Buy
985,114
+210,500
+27% +$73.5K ﹤0.01% 3864
2017
Q4
$238K Sell
774,614
-74,815
-9% -$23K ﹤0.01% 3900
2017
Q3
$620K Buy
849,429
+368,947
+77% +$269K ﹤0.01% 3702
2017
Q2
$606K Sell
480,482
-292,434
-38% -$369K ﹤0.01% 3690
2017
Q1
$889K Buy
772,916
+2,070
+0.3% +$2.38K ﹤0.01% 3614
2016
Q4
$1.62M Sell
770,846
-217,292
-22% -$456K ﹤0.01% 3428
2016
Q3
$4.44M Buy
988,138
+9,124
+0.9% +$41K ﹤0.01% 3065
2016
Q2
$4.44M Buy
979,014
+30,369
+3% +$138K ﹤0.01% 3045
2016
Q1
$4.41M Buy
948,645
+15,093
+2% +$70.2K ﹤0.01% 3031
2015
Q4
$5.04M Buy
933,552
+54,782
+6% +$296K ﹤0.01% 2983
2015
Q3
$5M Buy
878,770
+218,999
+33% +$1.25M ﹤0.01% 2969
2015
Q2
$6.7M Buy
659,771
+97,649
+17% +$991K ﹤0.01% 2872
2015
Q1
$3.83M Buy
562,122
+180,720
+47% +$1.23M ﹤0.01% 3121
2014
Q4
$1.64M Buy
381,402
+2,500
+0.7% +$10.8K ﹤0.01% 3352
2014
Q3
$1.74M Buy
378,902
+13,640
+4% +$62.5K ﹤0.01% 3322
2014
Q2
$1.28M Buy
365,262
+19,500
+6% +$68.2K ﹤0.01% 3420
2014
Q1
$1.98M Buy
345,762
+38,587
+13% +$221K ﹤0.01% 3226
2013
Q4
$1.76M Buy
307,175
+18,682
+6% +$107K ﹤0.01% 3237
2013
Q3
$2.07M Buy
288,493
+132,590
+85% +$952K ﹤0.01% 3117
2013
Q2
$1.09M Buy
+155,903
New +$1.09M ﹤0.01% 3286